FGFR2 and gastric carcinoma: However, the proportion of FGFR2-amplified tumors in the overall cohort was slightly higher in the group of gastric carcinomas with intestinal histology (13/187, 7.0%) than that of tumors with diffuse morphology (13/225, 5.1%), possibly due to the distribution of the investigated subtypes.